GATA-binding protein 4 (GATA-4) and T-cell acute leukemia 1 (TAL1) regulate myogenic differentiation and erythropoietin response via cross-talk with Sirtuin1 (Sirt1)

Journal of Biological Chemistry

Volumn 287, Issue 36, 2012, Pages 30157-30169

  Wang, Li ^a   Jia, Yi ^a   Rogers, Heather ^a   Wu, Yun Ping ^a   Huang, Suming ^b   Noguchi, Constance Tom ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; BASIC HELIX LOOP HELIXES; CYTOKINES; DEACETYLASE; ERYTHROPOIETIN (EPO); MUSCLE PROGENITOR CELLS; OVER-EXPRESSION; REGULATORY FACTORS; UNDERLYING MECHANISM;

CELL PROLIFERATION;

CROSSTALK;

ERYTHROPOIETIN; MYOD PROTEIN; MYOGENIC FACTOR; MYOGENIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SIRTUIN 1; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR TAL1;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GATA 4 GENE; GENE; GENE ACTIVATION; HORMONE ACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; MOUSE; MYOBLAST; MYOGENIN GENE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; SKELETAL MUSCLE; TAL1 GENE; TRANSCRIPTION REGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINE; ERYTHROPOIETIN; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MUSCLE DEVELOPMENT; MYOBLASTS, SKELETAL; MYOGENIN; PROTO-ONCOGENE PROTEINS; RESPONSE ELEMENTS; SIRTUIN 1;

EID: 84865714638     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.376640     Document Type: Article

References (55)

1. Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T. K., Turner, D., Rupp, R., and Hollenberg, S. (1991) The myoD gene family. Nodal point during specification of the muscle cell lineage. Science 251, 761-766
2. Rudnicki, M. A., Schnegelsberg, P. N., Stead, R. H., Braun, T., Arnold, H. H., and Jaenisch, R. (1993) MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75, 1351-1359
3. Nabeshima, Y., Hanaoka, K., Hayasaka, M., Esumi, E., Li, S., Nonaka, I., and Nabeshima, Y. (1993) Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364, 532-535
4. Lu, J., McKinsey, T. A., Zhang, C. L., and Olson, E. N. (2000) Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6, 233-244
5. Mal, A., Sturniolo, M., Schiltz, R. L., Ghosh, M. K., and Harter, M. L. (2001) A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD. Inhibition of the myogenic program. EMBO J. 20, 1739-1753
6. Puri, P. L., Iezzi, S., Stiegler, P., Chen, T. T., Schiltz, R. L., Muscat, G. E., Giordano, A., Kedes, L., Wang, J. Y., and Sartorelli, V. (2001) Class I histone deacetylases sequentially interact withMyoDand pRb during skeletal myogenesis. Mol. Cell 8, 885-897
7. Landry, J., Sutton, A., Tafrov, S. T., Heller, R. C., Stebbins, J., Pillus, L., and Sternglanz, R. (2000) The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. U.S.A. 97, 5807-5811
8. Imai, S., Armstrong, C. M., Kaeberlein, M., and Guarente, L. (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800
9. Michan, S., and Sinclair, D. (2007) Sirtuins in mammals. Insights into their biological function. Biochem. J. 404, 1-13
10. Fulco, M., Schiltz, R. L., Iezzi, S., King, M. T., Zhao, P., Kashiwaya, Y., Hoffman, E., Veech, R. L., and Sartorelli, V. (2003) Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell 12, 51-62
11. Lin, C. S., Lim, S. K., D'Agati, V., and Costantini, F. (1996) Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev. 10, 154-164
12. Wu, H., Liu, X., Jaenisch, R., and Lodish, H. F. (1995) Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83, 59-67
13. Ogilvie, M., Yu, X., Nicolas-Metral, V., Pulido, S. M., Liu, C., Ruegg, U. T., and Noguchi, C. T. (2000) Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J. Biol. Chem. 275, 39754-39761
14. Anagnostou, A., Liu, Z., Steiner, M., Chin, K., Lee, E. S., Kessimian, N., and Noguchi, C. T. (1994) Erythropoietin receptor mRNA expression in human endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 91, 3974-3978
15. Morishita, E., Masuda, S., Nagao, M., Yasuda, Y., and Sasaki, R. (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76, 105-116
16. Jia, Y., Warin, R., Yu, X., Epstein, R., and Noguchi, C. T. (2009) Erythropoietin signaling promotes transplanted progenitor cell survival. Faseb J. 23, 3089-3099
17. Jia, Y., Suzuki, N., Yamamoto, M., Gassmann, M., and Noguchi, C. T. (2012) Endogenous erythropoietin signaling facilitates skeletal muscle repair and recovery following pharmacologically induced damage. FASEB J. 26, 2847-2858
18. Hojman, P., Brolin, C., Gissel, H., Brandt, C., Zerahn, B., Pedersen, B. K., and Gehl, J. (2009) Erythropoietin overexpression protects against diet-induced obesity in mice through increased fat oxidation in muscles. PLoS One 4, e5894
19. Ravet, E., Reynaud, D., Titeux, M., Izac, B., Fichelson, S., Roméo, P. H., Dubart-Kupperschmitt, A., and Pflumio, F. (2004) Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis. Blood 103, 3326-3335
20. Kassouf, M. T., Chagraoui, H., Vyas, P., and Porcher, C. (2008) Differential use of SCL/TAL-1 DNA-binding domain in developmental hematopoiesis. Blood 112, 1056-1067
21. Rogers, H. M., Yu, X., Wen, J., Smith, R., Fibach, E., and Noguchi, C. T. (2008) Hypoxia alters progression of the erythroid program. Exp. Hematol. 36, 17-27
22. Molkentin, J. D., Lin, Q., Duncan, S. A., and Olson, E. N. (1997) Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 11, 1061-1072
23. Kuo, C. T., Morrisey, E. E., Anandappa, R., Sigrist, K., Lu, M. M., Parmacek, M. S., Soudais, C., and Leiden, J. M. (1997) GATA-4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 11, 1048-1060
24. Suzuki, Y. J., and Evans, T. (2004) Regulation of cardiac myocyte apoptosis by the GATA-4 transcription factor. Life Sci. 74, 1829-1838
25. Xin, M., Davis, C. A., Molkentin, J. D., Lien, C. L., Duncan, S. A., Richardson, J. A., and Olson, E. N. (2006) A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc. Natl. Acad. Sci. U.S.A. 103, 11189-11194
26. Salisch, S., Klar, M., Thurisch, B., Bungert, J., and Dame, C. (2011) Gata4 and Sp1 regulate expression of the erythropoietin receptor in cardiomyocytes. J. Cell. Mol. Med. 15, 1963-1972
27. Sumanas, S., Gomez, G., Zhao, Y., Park, C., Choi, K., and Lin, S. (2008) Interplay among Etsrp/ER71, Scl, and Alk8 signaling controls endothelial and myeloid cell formation. Blood 111, 4500-4510
28. Ema, M., Faloon, P., Zhang, W. J., Hirashima, M., Reid, T., Stanford, W. L., Orkin, S., Choi, K., and Rossant, J. (2003) Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev. 17, 380-393
29. Bussmann, J., Bakkers, J., and Schulte-Merker, S. (2007) Early endocardial morphogenesis requires Scl/Tal1. PLoS Genet. 3, e140
30. Jiang, C., Qu, A., Matsubara, T., Chanturiya, T., Jou, W., Gavrilova, O., Shah, Y. M., and Gonzalez, F. J. (2011) Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice. Diabetes 60, 2484-2495
31. Goldfarb, A. N., and Lewandowska, K. (1995) Inhibition of cellular differentiation by the SCL/tal oncoprotein. Transcriptional repression by an Id-like mechanism. Blood 85, 465-471
32. Hofmann, T. J., and Cole, M. D. (1996) The TAL1/Scl basic helix-loophelix protein blocks myogenic differentiation and E-box dependent transactivation. Oncogene 13, 617-624
33. Das, M., Wilson, K., Molnar, P., and Hickman, J. J. (2007) Differentiation of skeletal muscle and integration of myotubes with silicon microstructures using serum-free medium and a synthetic silane substrate. Nat. Protoc. 2, 1795-1801
34. Wen, J., Huang, S., Pack, S. D., Yu, X., Brandt, S. J., and Noguchi, C. T. (2005) Tal1/SCL binding to pericentromeric DNA represses transcription. J. Biol. Chem. 280, 12956-12966
35. Ustanina, S., Carvajal, J., Rigby, P., and Braun, T. (2007) The myogenic factor Myf5 supports efficient skeletal muscle regeneration by enabling transient myoblast amplification. Stem Cells 25, 2006-2016
36. Zhang, K., Sha, J., and Harter, M. L. (2010) Activation of Cdc6 by MyoD is associated with the expansion of quiescent myogenic satellite cells. J. Cell Biol. 188, 39-48
37. 1/S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/Akt signaling pathway. J. Biol. Chem. 275, 35942-35952
38. +-linked glycerol phosphate dehydrogenase has normal pancreatic beta cell function but abnormal metabolite pattern in skeletal muscle. Arch. Biochem. Biophys. 384, 143-153
39. Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., and Puigserver, P. (2005) Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434, 113-118
40. Hu, X., Li, X., Valverde, K., Fu, X., Noguchi, C., Qiu, Y., and Huang, S. (2009) LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc. Natl. Acad. Sci. U.S.A. 106, 10141-10146
41. Shea, K. L., Xiang, W., LaPorta, V. S., Licht, J. D., Keller, C., Basson, M. A., and Brack, A. S. (2010) Sprouty1 regulates reversible quiescence of a self-renewing adult muscle stem cell pool during regeneration. Cell Stem Cell 6, 117-129
42. Fulco, M., Cen, Y., Zhao, P., Hoffman, E. P., McBurney, M. W., Sauve, A. A., and Sartorelli, V. (2008) Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of NAMPT. Dev. Cell 14, 661-673
43. Rojas, A., Kong, S. W., Agarwal, P., Gilliss, B., Pu, W. T., and Black, B. L. (2008) GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart fieldderived myocardium. Mol. Cell Biol. 28, 5420-5431
44. Dey, S., Curtis, D. J., Jane, S. M., and Brandt, S. J. (2010) The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors. Mol. Cell Biol. 30, 2181-2192
45. Santra, M. K., Wajapeyee, N., and Green, M. R. (2009) F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature 459, 722-725
46. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado De Oliveira, R., Leid, M., McBurney, M. W., and Guarente, L. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 429, 771-776
47. Gerhart-Hines, Z., Rodgers, J. T., Bare, O., Lerin, C., Kim, S. H., Mostoslavsky, R., Alt, F. W., Wu, Z., and Puigserver, P. (2007) Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α. EMBO J. 26, 1913-1923
48. Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., Hu, L. S., Cheng, H. L., Jedrychowski, M. P., Gygi, S. P., Sinclair, D. A., Alt, F. W., and Greenberg, M. E. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015
49. Calvanese, V., Lara, E., Suárez-Alvarez, B., Abu Dawud, R., Vázquez-Chantada, M., Martínez-Chantar, M. L., Embade, N., López-Nieva, P., Horrillo, A., Hmadcha, A., Soria, B., Piazzolla, D., Herranz, D., Serrano, M., Mato, J. M., Andrews, P. W., López-Larrea, C., Esteller, M., and Fraga, M. F. (2010) Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc. Natl. Acad. Sci. U.S.A. 107, 13736-13741
50. Lecointe, N., Bernard, O., Naert, K., Joulin, V., Larsen, C. J., Romeo, P. H., and Mathieu-Mahul, D. (1994) GATA- and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene. Oncogene 9, 2623-2632
51. Göttgens, B., Nastos, A., Kinston, S., Piltz, S., Delabesse, E. C., Stanley, M., Sanchez, M. J., Ciau-Uitz, A., Patient, R., and Green, A. R. (2002) Establishing the transcriptional program for blood. The SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors. EMBO J. 21, 3039-3050
52. Sinclair, A. M., Göttgens, B., Barton, L. M., Stanley, M. L., Pardanaud, L., Klaine, M., Gering, M., Bahn, S., Sanchez, M., Bench, A. J., Fordham, J. L., Bockamp, E., and Green, A. R. (1999) Distinct 5′ SCL enhancers direct transcription to developing brain, spinal cord, and endothelium. Neural expression is mediated by GATA factor binding sites. Dev. Biol. 209, 128-142
53. Kassouf, M. T., Hughes, J. R., Taylor, S., McGowan, S. J., Soneji, S., Green, A. L., Vyas, P., and Porcher, C. (2010) Genome-wide identification of TAL1's functional targets. Insights into its mechanisms of action in primary erythroid cells. Genome Res 20, 1064-1083
54. Palii, C. G., Perez-Iratxeta, C., Yao, Z., Cao, Y., Dai, F., Davison, J., Atkins, H., Allan, D., Dilworth, F. J., Gentleman, R., Tapscott, S. J., and Brand, M. (2011) Differential genomic targeting of the transcription factor TAL1 in alternate hematopoietic lineages. EMBO J. 30, 494-509
55. Hu, X., Ybarra, R., Qiu, Y., Bungert, J., and Huang, S. (2009) Transcriptional regulation by TAL1. A link between epigenetic modifications and erythropoiesis. Epigenetics 4, 357-361